Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

Sanofi (SNY) Debt to Equity (2016 - 2025)

Sanofi's Debt to Equity history spans 12 years, with the latest figure at $0.26 for Q4 2025.

  • On a quarterly basis, Debt to Equity rose 26.17% to $0.26 in Q4 2025 year-over-year; TTM through Dec 2025 was $0.26, a 26.17% increase, with the full-year FY2025 number at $0.26, up 26.17% from a year prior.
  • Debt to Equity hit $0.26 in Q4 2025 for Sanofi, up from $0.21 in the prior quarter.
  • Over the last five years, Debt to Equity for SNY hit a ceiling of $0.3 in Q4 2021 and a floor of $0.21 in Q4 2024.
  • Historically, Debt to Equity has averaged $0.25 across 5 years, with a median of $0.25 in 2022.
  • Biggest five-year swings in Debt to Equity: dropped 17.12% in 2021 and later grew 26.17% in 2025.
  • Tracing SNY's Debt to Equity over 5 years: stood at $0.3 in 2021, then fell by 13.93% to $0.25 in 2022, then fell by 13.0% to $0.22 in 2023, then fell by 6.76% to $0.21 in 2024, then rose by 26.17% to $0.26 in 2025.
  • Business Quant data shows Debt to Equity for SNY at $0.26 in Q4 2025, $0.21 in Q4 2024, and $0.22 in Q4 2023.